SR
Shraddha Rupesh Yeola
About Shraddha Rupesh Yeola
Data last updated:
Shraddha Rupesh Yeola is a Director at Innovativ Biosciences Private Limited (since 2017) and Director at Belrich Pharmaceuticals (Opc) Private Limited (since 2025). The companies operate in Healthcare and Pharma. The largest current company by reported revenue is Innovativ Biosciences Private Limited at ₹1.59 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Innovativ Biosciences Private Limited U52601MH2016PTC280289 | Director | 21 Dec 2017 | 2016 | ₹1.59 Cr (FY 2025) | Active |
 Belrich Pharmaceuticals (Opc) Private Limited U41001PN2025OPC242384 | Director | 24 May 2025 | 2025 | Active |
Board colleagues of Shraddha Rupesh Yeola
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rupesh Ratnakar Yeola | 07437982 | Innovativ Biosciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shraddha Rupesh Yeola
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shraddha Rupesh Yeola
Shraddha Rupesh Yeola currently holds 2 directorships: Innovativ Biosciences Private Limited (Director, since 21 Dec 2017, revenue ₹1.59 Cr (FY 2025)); Belrich Pharmaceuticals (Opc) Private Limited (Director, since 24 May 2025).
Shraddha Rupesh Yeola was first appointed on 21 Dec 2017 as Director at Innovativ Biosciences Private Limited. The most recent appointment on record is 24 May 2025 at Belrich Pharmaceuticals (Opc) Private Limited.
The current boards of Shraddha Rupesh Yeola's companies include Rupesh Ratnakar Yeola (Innovativ Biosciences Private Limited).